Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3478 Peptide Receptor Radionuclide Therapy with 177Lutethium or 90Yttrium- DOTA-TATE or –TOC in Malignant Pheochromocytomas (PCCs) and Paragangliomas (PGLs): Results from a single institutional retrospective analysis

Introduction: Malignant pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare tumors and limited systemic therapies are available so far.

Conference:

Presenting Author: Rubino M

Authors: Rubino M, Di Stasio G, Spada F, Rocca P, Laffi A,

Keywords: Pheochromocytoma, Paraganglioma, Peptide Receptor Radionuclide Therapy, 90Y, 177Lu,

#1203 Atypical Bronchial Carcinoid: Different Therapeutical Approachs

Introduction: Choosing an adequate treatment for atypical bronchial carcinoid can improve quality of life and survival.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Geraldo Roig L,

Keywords: 68GaDOTATOC PET-CT, neuroendocrine tumor, atypical bronchial carcinoid, octreotide, PRRT,

#1154 Selective Internal Radiation Therapy (SIRT) Radioembolisation with 90 Yttrium in Patients with Unresectable Liver Neuroendocrine Metastases in a Specialized Center. An Initial Report

Introduction: Most patients with neuroendocrine tumors present liver metastases at some point of the clinical course. Liver directed treatment, such as 90 Yttrium is a method of treatment used in patients with non-resectable liver lesions, which is effective in the control of symptoms and tumor growth.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: García Mónaco R

Authors: García Mónaco R, Peralta O, O'Connor J, Pesce V, Bestani C,

Keywords: 90Yttrium, radioembolization, neuroendocrine tumors ,

#768 Long-Term Haematological and Renal Toxicity of 90Yttrium-DOTA-Octreotate in the Treatment of Advanced Neuroendocrine Tumors(NETs)

Introduction: Peptide receptor radiation therapy (PRRT) is an established treatment for advanced NETs. Renal/haematological toxicity are recognised adverse effects.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: MELVILLE A

Authors: Melville A, Cheung V, Garcia-Hernandez J, Pericleous M, Navalkissoor S,

Keywords: NET, PRRT, renal toxicity, bone marrow toxicity, Yttrium90,

#21 Peptide Receptor Radioligand Therapy (PRRT) is an Effective Treatment for the Long-Term Stabilization of Malignant Gastrinomas

Introduction: Gastrinomas represent a rare group of neuroendocrine tumors usually located in the duodenum or pancreas. They secrete gastrin, which is responsible for the clinical picture of severe acid-related peptic disease and diarrhea, known as the Zollinger-Ellison syndrome (ZES). While symptomatic control may be achieved with proton-pump inhibitors (PPIs) and somatostatin analogues (SSAs) treatment, little data is known regarding the possible anti-tumor effect of the peptide receptor radioligand therapy (PRRT) in gastrinoma patients.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Grozinsky-Glasberg S, Barak D, Fraenkel M, Müeller J, Shimon I,

Keywords: PRRT, malignant gastrinoma, treatment, anti-tumor effect ,